EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lavandula angustifolia mill. (Lamiaceae) ethanol extract and its main constituents as promising agents for the treatment of metabolic disorders: chemical profile, in vitro biological studies, and molecular docking

Rosa Tundis, Fedora Grande, Maria A Occhiuzzi, Vincenzo Sicari, Monica R Loizzo, Anna R Cappello

Journal of Enzyme Inhibition and Medicinal Chemistry · 2023

DOI: 10.1080/14756366.2023.2269481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. Verfasst von Rosa Tundis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lavandula, Lamiaceae. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lavandula angustifolia Mill. (lavender) is one of the most used medicinal plants. Herein, we chemically characterised and investigated the antioxidant properties and the capability to inhibit key enzymes for the treatment of type 2 diabetes (TD2) and obesity such as pancreatic lipase, α-glucosidase, and α-amylase of the ethanolic extract of two lavender samples (La1 and La2) from southern Italy. Both extracts significantly inhibited α-glucosidase, while La1 inhibited α-amylase and lipase more effectively than La2. To investigate whether these properties could be due to a direct interaction of the main constituents of the extracts with the targeted enzymes, molecular docking studies have been performed. As a result, the selected compounds were able to interact with the key residues of the binding site of the three proteins, thus supporting biological data. Current findings indicate the new potential of lavender ethanolic extract for the development of novel agents for T2D and obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2LavandulaLamiaceaeMolecular Docking Simulationalpha-GlucosidasesEthanolPlant ExtractsAntioxidantsalpha-AmylasesLipaseObesity

Stichwörter der Autor:innen

LavenderUHPLC-DAD analysisantioxidant activityenzyme inhibitionin silico study

Substanzen

alpha-GlucosidasesEthanolPlant ExtractsAntioxidantsalpha-AmylasesLipase

Autor:innen und Institutionen

  • Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
  • Department of Agraria, Mediterranean University of Reggio Calabria, Reggio Calabria, Italy.

Zitieren

APA

Tundis, R., Grande, F., Occhiuzzi, M. A., Sicari, V., Loizzo, M. R., & Cappello, A. R. (2023). Lavandula angustifolia mill. (Lamiaceae) ethanol extract and its main constituents as promising agents for the treatment of metabolic disorders: chemical profile, in vitro biological studies, and molecular docking. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2023.2269481

Vancouver

Tundis R, Grande F, Occhiuzzi MA, Sicari V, Loizzo MR, Cappello AR. Lavandula angustifolia mill. (Lamiaceae) ethanol extract and its main constituents as promising agents for the treatment of metabolic disorders: chemical profile, in vitro biological studies, and molecular docking. Journal of Enzyme Inhibition and Medicinal Chemistry. 2023. doi:10.1080/14756366.2023.2269481

BibTeX
@article{Tundis2023,
  author = {Tundis, Rosa and Grande, Fedora and Occhiuzzi, Maria A and Sicari, Vincenzo and Loizzo, Monica R and Cappello, Anna R},
  title = {Lavandula angustifolia mill. (Lamiaceae) ethanol extract and its main constituents as promising agents for the treatment of metabolic disorders: chemical profile, in vitro biological studies, and molecular docking},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2023},
  doi = {10.1080/14756366.2023.2269481}
}
Kostenlos starten →